Enrique Luna, E. Fuentes, Millán, F. Caravaca, J. Saenz-de-Santamaría, M. L. Vargas, M. Bayo, B. Gonzales, G. Sanchez-Pino, E. Sánchez-Casado
{"title":"早期使用螺内酯或氯沙坦治疗肾移植后HVI消退的前瞻性随机对照研究[XXXVII SEDYT 2015]","authors":"Enrique Luna, E. Fuentes, Millán, F. Caravaca, J. Saenz-de-Santamaría, M. L. Vargas, M. Bayo, B. Gonzales, G. Sanchez-Pino, E. Sánchez-Casado","doi":"10.1016/j.dialis.2015.04.032","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100373,"journal":{"name":"Diálisis y Trasplante","volume":"99 1","pages":"61-61"},"PeriodicalIF":0.0000,"publicationDate":"2015-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Estudio prospectivo controlado aleatorizado sobre el uso precoz de espironolactona o losartán en la regresión de la HVI postrasplante renal [XXXVII SEDYT 2015]\",\"authors\":\"Enrique Luna, E. Fuentes, Millán, F. Caravaca, J. Saenz-de-Santamaría, M. L. Vargas, M. Bayo, B. Gonzales, G. Sanchez-Pino, E. Sánchez-Casado\",\"doi\":\"10.1016/j.dialis.2015.04.032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100373,\"journal\":{\"name\":\"Diálisis y Trasplante\",\"volume\":\"99 1\",\"pages\":\"61-61\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diálisis y Trasplante\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.dialis.2015.04.032\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diálisis y Trasplante","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.dialis.2015.04.032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Estudio prospectivo controlado aleatorizado sobre el uso precoz de espironolactona o losartán en la regresión de la HVI postrasplante renal [XXXVII SEDYT 2015]